http://galmedpharma.com/2021/10/11/results-of-galmeds-phase-2b-arrest-trial-of-aramchol-published-in-nature-medicine/2021-10-11T12:00:00+00:00http://galmedpharma.com/2021/08/19/galmed-pharmaceuticals-announces-publication-in-the-journal-of-autoimmunity-for-its-ind-ready-amilo-5mer-a-specific-anti-inflammatory-compound/2021-08-19T12:00:00+00:00http://galmedpharma.com/2021/08/16/mhra-agrees-with-galmeds-plan-to-use-aramchol-meglumine-in-the-randomized-double-blind-placebo-controlled-part-of-the-phase-3-armor-study/2021-08-16T12:00:00+00:00